News and Articles


FOR IMMEDIATE RELEASE
Contact: Dr. Burns
E-mail:   drburns@evaluationtoday.com

DrBurns ReLeaf New Cannabis-infused Product Line

Scottsdale, Arizona. Medical marijuana patients often encounter a gap between what they are prescribed at their certification and availability of the recommended medications when they visit the dispensary. With the recent introduction of a new physician-formulated line of cannabis-infused products, Dr. Elaine Burns, Medical Director of Southwest Medical Marijuana Evaluation Center, located in Scottsdale at 8010 E. McDowell Road, Suite 105, has addressed that gap. The products will soon be available as Drburns ReLeaf at many legally licensed Arizona dispensaries. This new product line bridges the gap between what the physician wants for their patient and what is actually available.

Dr. Burns developed Drburns ReLeaf to ensure patients have access to consistently high quality therapeutic products. Since there is no stipulation in the medical marijuana act requiring dispensaries to test medications for therapeutic safety and effectiveness, she has been working in conjunction with several dispensaries to create physician-formulated products that are safe, tested and locally produced rather than sourced out of state. Dr. Burns drew on over six years of significant clinical experience with medical marijuana patients to develop the Drburns ReLeaf products. They are based on scientific studies, not just folklore, grandma’s remedies or old wives’ tales. They raise the bar of quality control for the entire industry.

Just as allopathic physicians are educated in the nuances of various pharmaceuticals, medical marijuana evaluation physicians make it a point to understand the various types of medication available and which ones are most appropriate to treat specific complaints. But stock at dispensaries is constantly changing, often making it difficult for patients to get the medication their doctor has prescribed.

THC levels which cause the “high” traditionally associated with cannabis are one significant concern. “Medical marijuana patients do not want to get high. They just want to get better and feel better. And better does not necessarily mean high,” commented Dr. Burns. “Therapy patients, for example, do not need medication that is strong in THC and yet, many of the products they find will have high THC levels.” In keeping with Dr. Burns’ dedication to educating patients and recommending the most appropriate medication for a patient’s condition, the new product line addresses that issue.

levels which cause the “high” traditionally associated with cannabis are one significant concern. “Medical marijuana patients do not want to get high. They just want to get better and feel better. And better does not necessarily mean high,” commented Dr. Burns.  “Therapy patients, for example, do not need medication that is strong in THC and yet, many of the products they find will have high THC levels.” In keeping with Dr. Burns’ dedication to educating patients and recommending the most appropriate medication for a patient’s condition, the new product line addresses that issue.

The transition from recreational pot to medical marijuana has created a whole new world. Originally a spillover from recreational marijuana, the first medical marijuana products were developed based on experience with recreational cannabis. They were, however, often driven by high THC levels and were not necessarily therapeutic. But therapeutic medications are the whole point of medical marijuana. As scientific evidence and anecdotal experience with the medical aspects of marijuana have mounted, marijuana’s high-producing properties have increasingly lost ground to its therapeutic value.

 Dr. Burns, an Arizona-licensed and board-certified Naturopathic Medical Doctor (NMD), is the founder and Medical Director of the Southwest Medical Marijuana Evaluation Center.  She has been instrumental in building an ethical, highly professional medical marijuana industry in Arizona since 2011 and was recently appointed to the board for AMMA PAC, the Arizona Medical Marijuana Act Political Action Committee. As the state’s first Certified Expert in Cannabis Medicine, Dr.  Burns has been integral in setting professional standards within Arizona’s medical marijuana community. Those standards have become a hallmark of the treatment patients can expect at the top rated Southwest Medical Marijuana Evaluation Center.

Southwest Medical Marijuana Evaluation Center and Dr. Burns have been advocating for and educating patients in the Phoenix metropolitan area since 2011. In addition to a Mobile Unit that travels around the state, Southwest Medical Marijuana Evaluation Center is located in north Phoenix at 12620 N. Cave Creek Road, Suite 7, in south Scottsdale at 8010 E. McDowell Road, Suite 105 and in Avondale at 10320 W. McDowell Rd, Suite B2006.

Dr. Burns, an Arizona-licensed and board-certified Naturopathic Medical Doctor (NMD), is the founder and Medical Director of the Southwest Medical Marijuana Evaluation Center. She has been instrumental in building an ethical, highly professional medical marijuana industry in Arizona since 2011. As the state’s first Certified Expert in Cannabis Medicine, Dr. Burns has been integral in setting professional standards within Arizona’s medical marijuana community. Those standards have become a hallmark of the treatment patients can expect at Southwest Medical Marijuana Evaluation Center. In addition to a Mobile Unit that travels around the state, Southwest Medical Marijuana Evaluation Center is located in north Phoenix at 12620 N. Cave Creek Road, Suite 7, in south Scottsdale at 8010 E. McDowell Road, Suite 105 and now in Avondale at 10320 W. McDowell Rd, Suite B2006. For further information, contact Dr. Elaine Burns at 480-656-2119 or email her directly at drburns@evaluationtoday.com.

Improving the quality of life for every patient.